Impact of Fetuin-A, Lp(a), matrix gla protein and macrophage density on calcific aortic valve disease: a clinical

Cong Liu1,2,3, Haifeng Liu4, Ting Xie5

  • 1Department of Ultrasound Medicine, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, 430022, Wuhan, China.

Insights

Calcific aortic valve disease (CAVD) is increasing in older adults. Fetuin-A, MGP, and Lp(a) are linked to CAVD occurrence and may predict its diagnosis.

Area of Science:

  • Cardiology
  • Biochemistry
  • Geriatrics

Background:

  • Calcific aortic valve disease (CAVD) presents a growing health challenge, particularly in aging populations, often with subtle initial symptoms.
  • Understanding the clinical factors associated with CAVD is crucial for early detection and management.

Purpose of the Study:

  • To investigate the association between various clinical characteristics and the incidence of calcific aortic valve disease (CAVD).
  • To identify potential biomarkers for the diagnosis of CAVD.

Main Methods:

  • A retrospective study involving patients diagnosed with CAVD and healthy controls between January 2019 and February 2021.
  • Collection and comparison of clinical, ultrasonic, serological, and histological data.
  • Logistic regression and Pearson correlation analyses were employed to determine associations.

Main Results:

  • Elevated levels of Fetuin-A and Lp(a) and reduced levels of MGP were significantly associated with CAVD occurrence.
  • Fetuin-A and Lp(a) showed a positive correlation with disease progression, while MGP and macrophage density exhibited a negative correlation.
  • Several clinical and serological indicators, including blood pressure and lipid profiles, differed significantly across disease severity groups.

Conclusions:

  • Fetuin-A, MGP, and Lp(a) are independently associated with the occurrence of CAVD.
  • These factors demonstrate potential as predictive biomarkers for the diagnosis of calcific aortic valve disease.
Abstract